FOQUEST

Identification of Foquest

No description

Google image searchProduct monograph

Active ingredient

methylphenidate hydrochloride, 55 MG

DIN: 02470322

Dosage form(s): CAPSULE (CONTROLLED RELEASE)

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA III)

Company: ELVIUM LIFE SCIENCES

Date: 08-SEP-2020

ATC:

Reference brand drug: Biphentin, Concerta, Ritalin

Search on Google